Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients

Transplantation

Volumn 65, Issue 7, 1998, Pages 956-965

  Garcia Morales, Rolando ^a   Carreno, Manuel ^a   Mathew, James ^a   Cirocco, Robert ^a   Zucker, Keith ^a   Ciancio, Gaetano ^a   Burke, George ^a   Roth, David ^a   Temple, Donald ^a   Fuller, Laphalle ^a   Esquenazi, Violet ^a   Eskind, Lon ^a   Kenyon, Norma S ^a   Ricordi, Camillo ^a   Tzakis, Andreas ^a   Miller, Joshua ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 3; TACROLIMUS;

ARTICLE; CADAVER DONOR; CHIMERA; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE DONORS; TRANSPLANTATION CHIMERA;

EID: 0032522367     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00016     Document Type: Article

References (34)

1. Garcia-Morales R, Carreno M, Mathew J, et al. The effects of chimeric cells following donor bone marrow infusions and detected by PCR-Flow assays in kidney transplant recipients. J Clin Invest 1997; 99: 1118.
2. Garcia-Morales R, Esquenazi V, Zucker K, et al. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-Flow). Transplantation 1996; 62: 1149.
3. Ciancio G, Rosen A, Loreto-Grand B, et al. The current advantage of FK506 in cadaver transplantation. Transplant Proc 1996; 28: 1000.
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
5. Ricordi C, Karatzas T, Nery J, et al. High-dose human donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997; 63: 7.
6. Ricordi C, Karatzas T, Selvaggi G, et al. Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans. Transplant Proc 1995; 27: 3381.
7. English D, Lamberson R, Graves V, Akard LP, McCarthy LJ, Jansen J. Serial automated processing of bone marrow grafts for transplantation. Transfusion 1989; 29: 12.
8. Mathew JM, Carreno M, Fuller L, Ricordi C, Tzakis A, Esquenazi V, Miller J. Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 1996; 63: 71.
9. Schmidt-Wolf IG, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S. T-cell subsets and suppressor cells in human bone marrow. Blood 1992; 80: 3242.
10. Gehrz RC, Fuad S, Liu YC, Bach FH. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). J Immunol 1987; 138: 3145.
11. Salvatierra O Jr, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. Ann Surg 1980; 192; 543.
12. Anderson CB, Tyler JD, Sicard GA, Anderman CK, Rodey GE, Etheredge EE. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood. Transplantation 1984; 38: 664.
13. Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW. Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976; 79: 384.
14. Monaco AP, Wood ML, Maki T, Madras RN, Sahyoun AI, Simpson MA. Attempts to induce unresponsiveness to renal allografts with anti-lymphocyte globulin and donor-specific bone marrow. Transplant Proc 1985; 17: 1312.
15. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
16. McDaniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57: 852.
17. Fontes P, Rao A, Demetris AJ, et al. Augmentation with bone marrow of donor migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
18. Rao AS, Fontes P, Zeevi A, et al. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc 1995; 27: 210.
19. Shapiro R, Rao AS, Fontes P, et al. Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995; 60: 1421.
20. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of the novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436.
21. Ildstad ST, Bluestone JA, Sachs DH. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn - 057BL/10Sn). J Exp Med 1986; 163: 1343.
22. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
23. MacDonald HRH. NK1.1+ T cell receptor-αβ+ cells: new clues to their origin, specificity, and function. J Exp Med 1995; 182: 633.
24. Ricordi C, Ildstad ST, Demetris AJ, Abou el-Ezz AY, Murase N, Starzl TE. Donor dendritic cell repopulation in recipients after rat-to-mouse bone marrow transplantation. Lancet 1992; 339: 1610.
25. Jin Y, Fuller L, Carreno M, et al. The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage. J Clin Immunol 1997; 17: 140.
26. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577; Discussion 588.
27. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996; 17: 584; Discussion 588.
28. Shapiro F, Martinez C, Smith JM, Good RA. Tolerance of skin monografts in adult mice by multiple injections of homologous spleen cells. Proc Soc Exp Biol Med 1961; 106: 472.
29. McKhann C. Weak histocompatibility genes: the effect of dose and pretreatment of immunizing cells. J Immunol 1962; 88: 500.
30. Blaese MR, Martinez C, Good RA. Immunologic incompetence of immunologically runted mice. J Exp Med 1964; 119: 211.
31. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
32. Zeevi A, Pavlick M, Lombardozzi S, et al. Immune status of recipients following bone marrow-augmented solid organ transplantation. Transplantation 1995; 59: 616.
33. Kiziroglu F, Miller RG. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells. J Immunol 1991; 146: 1104.
34. Van Twuyver E, Kast WM, Mooijaart RJD, Melief CJM, DeWaal LP. Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch: Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur. J Immunol 1990; 20: 441.